Doctors In Now · Evening OPD
    10-Bedded Hospital✦24/7 Emergency Care✦+91 90633 66983✦+91 95053 74057✦❤️ Best Neurologist in Hyderabad✦✦10-Bedded Hospital✦24/7 Emergency Care✦+91 90633 66983✦+91 95053 74057✦❤️ Best Neurologist in Hyderabad✦✦
    Back to all articlesNeurology

    Autoimmune Encephalitis: When the Brain Is Attacked by the Immune System

    Dr. Anand Karnam 2026-04-26 4 min
    Autoimmune Encephalitis: When the Brain Is Attacked by the Immune System

    Autoimmune encephalitis — the immune system attacking brain proteins — can cause psychosis, seizures, and coma. It is treatable but frequently mistaken for psychiatric illness. Dr. Anand Karnam explains the clues and the importance of early diagnosis.

    Key Points

    • Autoimmune encephalitis presents with rapid-onset psychiatric symptoms, seizures, movement disorders, and reduced consciousness.
    • Anti-NMDA receptor encephalitis is the most common type — most often affects young women and can follow ovarian teratoma.
    • Diagnosis requires antibody testing in both CSF and blood — serum alone misses some cases.
    • EEG shows characteristic 'extreme delta brush' pattern in anti-NMDA encephalitis.
    • Rapid immunotherapy (steroids, IVIG, plasma exchange) and tumour removal (if applicable) are life-saving.

    80%

    of anti-NMDA encephalitis patients recover with immunotherapy

    Source: Lancet Neurology

    50%

    of cases have an underlying ovarian teratoma — removal accelerates recovery

    Source: NCBI

    4–6 weeks

    typical time to significant clinical improvement after starting immunotherapy

    Source: NCBI

    "Autoimmune encephalitis presents like acute psychosis — agitation, hallucinations, bizarre behaviour — and gets admitted to psychiatry wards. The neurologist who thinks of this diagnosis and tests for antibodies can transform the outcome from permanent brain damage to full recovery."

    — Dr. Anand Karnam · DrNB Neurology · Sri Anand CNC, Chanda Nagar Hyderabad, Sri Anand Child and Neuro Center

    Autoimmune encephalitis (AE) — inflammation of the brain caused by antibodies against neuronal surface proteins — was only characterised and systematically described from 2007 onwards, but has rapidly become one of the most important causes of new-onset encephalopathy, especially in young people. The antibodies impair neuronal function and cause the clinical syndrome. The most common and paradigmatic form is anti-NMDA receptor encephalitis, but dozens of antibody-specific variants exist. AE is frequently misdiagnosed as psychiatric illness for weeks to months — a dangerous delay that worsens outcomes.

    Anti-NMDA Receptor Encephalitis — Stages of Presentation

    This condition disproportionately affects young women (but also men and children). The clinical course progresses through characteristic stages: Prodrome (1–2 weeks): Flu-like illness — headache, fever, fatigue. Psychiatric phase (2–4 weeks): Anxiety, agitation, paranoia, hallucinations (visual and auditory), behavioural change, insomnia. Patients are referred to psychiatry and treated with antipsychotics — which have minimal effect. Neurological phase: Seizures; abnormal involuntary movements (orofacial dyskinesias — chewing, grinding movements; limb choreiform movements); speech disorganisation and then mutism; autonomic instability (heart rate and BP fluctuations); progressive loss of consciousness. This is an ICU emergency.

    Red Flags That Should Prompt AE Testing

    New-onset psychiatric symptoms in a previously well young person with no psychiatric history; rapid deterioration over weeks; fever with psychiatric symptoms; seizures alongside psychiatric symptoms; orofacial dyskinesias; treatment-resistant psychiatric presentation; CSF pleocytosis (white cells — unusual in primary psychiatric illness).

    Treatment

    First-line: IV methylprednisolone + IV immunoglobulin (IVIG) or plasma exchange. Remove underlying tumour if present (30% of anti-NMDA encephalitis in adult women is associated with ovarian teratoma — removal is part of treatment). Second-line for non-responders: rituximab, cyclophosphamide. Prognosis is good with early treatment — most patients make substantial recovery. Delayed diagnosis worsens outcomes. Sri Anand CNC, Chanda Nagar, Hyderabad. Call +91 90633 66983.

    Have questions about this topic?

    Our specialist doctors at Sri Anand Child and Neuro Center can help — in person or via WhatsApp.

    K

    Dr. Anand Karnam

    DrNB Neurology · Sri Anand CNC, Chanda Nagar Hyderabad · Sri Anand Child and Neuro Center

    DrNB-qualified Neurologist, Fellow of the World Headache Society (FWHS), and Headache Specialist with 12+ years of experience treating epilepsy, stroke, migraine, and movement disorders. Practices at Sri Anand Child and Neuro Center, Chanda Nagar, Hyderabad.

    References & Sources

    1. 1.Autoimmune Encephalitis — NCBI StatPearls — NCBI StatPearls
    2. 2.Encephalitis — NIH MedlinePlus — NIH MedlinePlus
    3. 3.Encephalitis — NHS — NHS UK

    Health Information Standards

    IMA — Indian Medical Association

    Content follows IMA ethical guidelines for patient education

    WHO — World Health Organization

    Treatment information aligned with WHO clinical guidelines

    MoHFW — Govt. of India — Ministry of Health

    Follows MoHFW National Health Programme protocols

    NMC — National Medical Commission

    All doctors hold NMC-recognised qualifications (DrNB / MD / MPT)

    All health tips and medical content on this website are written by qualified specialist doctors (DrNB / MD / MPT), follow the above guidelines, and are intended for general health education only. This content is original and evidence-based — not a substitute for professional medical advice. Always consult your doctor before making any health decisions.

    Concerned about your health?

    Talk to our specialist doctors directly — WhatsApp response within minutes during clinic hours.

    Share:WhatsAppFacebook

    Talk to a Specialist

    Dr. Anand (Neuro) · Dr. Sushma (Paeds) · Dr. Harisha (Physio)

    Verified Health Info

    IMA GuidelinesWHO GuidelinesMoHFW GuidelinesNMC Guidelines